Skip Navigation

This Article
Right arrow FREE Full Text (Print PDF) Freely available
Right arrow FREE Full Text (Screen PDF)
Right arrow Comments: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Comments are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Lagunin, A.
Right arrow Articles by Poroikov, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lagunin, A.
Right arrow Articles by Poroikov, V.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Bioinformatics Vol. 16 no. 8 2000
Pages 747-748
© 2000 Oxford University Press

Applications Note

PASS: prediction of activity spectra for biologically active substances

Alexey Lagunin 1, Alla Stepanchikova 1, Dmitrii Filimonov 1 and Vladimir Poroikov 1

1 Laboratory of Structure-Function Based Drug Design, Institute of Biomedical Chemistry RAMS, Moscow, Pogodinskaya str., 10, 119832, Russia

Received on November 26, 1999 ; revised on December 11, 1999 ; accepted on March 21, 2000

Summary: The concept of the biological activity spectrum was introduced to describe the properties of biologically active substances. The PASS (prediction of activity spectra for substances) software product, which predicts more than 300 pharmacological effects and biochemical mechanisms on the basis of the structural formula of a substance, may be efficiently used to find new targets (mechanisms) for some ligands and, conversely, to reveal new ligands for some biological targets. We have developed a WWW interface for the PASS software. A WWW server for the on-line prediction of the biological activity spectra of substances has been constructed.

Availability: http://www.ibmh.msk.su/PASS/

Contact: pass{at}ibmh.msk.su


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Nucleic Acids ResHome page
M. Dunkel, S. Gunther, J. Ahmed, B. Wittig, and R. Preissner
SuperPred: drug classification and target prediction
Nucleic Acids Res., July 1, 2008; 36(suppl_2): W55 - W59.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
C. Di Giorgio, F. Delmas, N. Filloux, M. Robin, L. Seferian, N. Azas, M. Gasquet, M. Costa, P. Timon-David, and J.-P. Galy
In Vitro Activities of 7-Substituted 9-Chloro and 9-Amino-2-Methoxyacridines and Their Bis- and Tetra-Acridine Complexes against Leishmania infantum
Antimicrob. Agents Chemother., January 1, 2003; 47(1): 174 - 180.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
F. Delmas, C. Di Giorgio, M. Robin, N. Azas, M. Gasquet, C. Detang, M. Costa, P. Timon-David, and J.-P. Galy
In Vitro Activities of Position 2 Substitution-Bearing 6-Nitro- and 6-Amino-Benzothiazoles and Their Corresponding Anthranilic Acid Derivatives against Leishmania infantum and Trichomonas vaginalis
Antimicrob. Agents Chemother., August 1, 2002; 46(8): 2588 - 2594.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.